Updated COVID-19 booster awaiting FDA approval
New vaccines are being developed to boost immunity against the XBB.1.5 subvariant of COVID-19. There are no official timelines for the rollout of any of the new boosters yet.
Source: dailycal.org
Stay updated with breaking news from Human Service Bridge Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New vaccines are being developed to boost immunity against the XBB.1.5 subvariant of COVID-19. There are no official timelines for the rollout of any of the new boosters yet.